Outcomes following prenatal exposure to DTG-containing antiretroviral therapy regimens: data from the DOLOMITE-EPPICC study
26 Nov, 2024
Authors: Sconza R, Fernandes G, Bailey H, Aebi-Popp K, Ene L, Floridia M, Gamell MA, Ramos IM, Peters H, Samarina A, Ragone L, Vannappagari V,Thorne C for Dolomite-EPPICC Study Group